Freedom Investment Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Freedom Investment Management’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,220	Closed	-$322K	–	1159
2017 Q1	$322K	Buy	3,220 +1,092	+51%	+$117K	0.02%	727
2016 Q4	$229K	Buy	+2,128	New	+$249K	0.01%	818
2016 Q1	–	Sell	-1,924	Closed	-$274K	–	911
2015 Q4	$274K	Buy	+1,924	New	+$222K	0.02%	591

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Freedom Investment Management's CBPO Position: Q2 2017 in Review

Freedom Investment Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2017, closing a stake of 3,220 shares — an estimated $322K sold.

Freedom Investment Management first reported a position in CBPO in Q4 2015 and held it in 3 quarters. The position peaked at $322K in Q1 2017. 119 funds tracked by Wall St. Rank hold CBPO as of Q2 2017.

Freedom Investment Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2017 after selling out during the quarter.
Freedom Investment Management sold 3,220 China Biologic Products Holdings, Inc. shares in Q2 2017, an estimated $322K.
Freedom Investment Management first reported a position in China Biologic Products Holdings, Inc. in Q4 2015 and held it in 3 quarters.
Freedom Investment Management's China Biologic Products Holdings, Inc. position peaked at $322K in Q1 2017.
119 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2017.

Based on Freedom Investment Management's 13F filing for Q2 2017, filed 14 Jul 2017.